Related Experiment Videos
Total ischemic burden: pathophysiology and prognosis
Insights
Silent myocardial ischemia, often without pain, significantly impacts cardiac prognosis. Aggressive treatment is crucial for patients with a high burden of silent ischemic episodes.
Area of Science:
- Cardiology
- Ischemic Heart Disease
Background:
- Myocardial ischemia results from supply-demand imbalance.
- Total ischemic burden includes both symptomatic and silent episodes.
- Silent myocardial ischemia (SMI) episodes can occur at lower heart rates, suggesting vasoconstriction.
Purpose of the Study:
- To explore the clinical significance of silent myocardial ischemia.
- To investigate the relationship between SMI and cardiac prognosis.
- To determine if aggressive therapy is warranted for significant SMI.
Main Methods:
- Analysis of myocardial ischemia episodes, both symptomatic and silent.
- Evaluation of prognostic impact of silent myocardial ischemia.
- Correlation of SMI duration and frequency with cardiac events.
Main Results:
- Silent myocardial ischemia may be clinically more significant than painful episodes.
- SMI is associated with adverse prognosis in asymptomatic and post-infarction patients.
- A direct relationship exists between SMI burden and cardiac events in unstable angina.
Conclusions:
- Silent myocardial ischemia significantly contributes to the total ischemic burden.
- Aggressive therapeutic strategies may be necessary for patients with substantial silent myocardial ischemia.
- Understanding and managing SMI is critical for improving cardiac outcomes.
Abstract:
Myocardial ischemia is caused by decreased supply (primary ischemia), increased demand (secondary ischemia) or a combination of the two (mixed ischemia). The sum of all episodes--with or without pain--constitutes the total ischemic burden. During out-of-hospital activities, many episodes occur at lower than expected heart rates, suggesting that a vasoconstrictive component is involved in the genesis of such episodes. These silent attacks may be even more important clinically than painful attacks. It has been suggested that silent myocardial ischemia has an adverse impact on prognosis in patients with totally asymptomatic ischemia or asymptomatic postinfarction ischemia. Further, it has been shown that there is a direct relation between the duration and frequency of silent myocardial ischemia and subsequent cardiac events in patients with unstable angina. Therefore, aggressive therapy may be warranted in certain groups of patients in whom silent myocardial ischemia constitutes a significant part of the total ischemic burden.